Health care startups in Boston, Massachusetts
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Ratio Therapeutics | Boston | Series C | $70.0M | 2026-07-31 |
| WHOOP | Boston | Series G | $575.0M | 2026-03-31 |
| PhaseV | Boston | Series A | $50.0M | 2025-05-13 |
| Origin | Boston | Series B | $56.0M | 2021-08-30 |
| VideaHealth | Boston | Series B | $40.0M | 2025-01-28 |
| Ascidian Therapeutics | Boston | Series A | $40.0M | 2023-11-08 |
| Lynx | Boston | Series A | $27.0M | 2025-02-06 |
| ZOE | Boston | Series B | $15.0M | 2024-07-29 |
8 rows of the CSV in 5 of its 18 columns.
- The 438 health care startups in Boston, Massachusetts have raised $16.8B in total.
- 71 of them closed their most recent round in the last 12 months, $2.4B combined.
- The largest of those rounds is WHOOP's $575.0M Series G, dated March 2026.
- The most recent is Delix Therapeutics' $100.0M Series C on 9 November 2026.
- MassChallenge is an investor in 18 of them, more than any other fund.
- Biotech is the most common other sector, with 175 companies (40%).
- 40% were founded in 2020 or later; the median founding year is 2018.
- The most common team size is 11 to 50 employees (42% of companies with a recorded size).
- 3 are unicorns, valued at $1 billion or more.
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
30 of 438| Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|
| Delix Therapeutics | Delix Therapeutics develops psychoplastogen therapies that promote neuroplasticity. | Biotech | Series C | $100.0M | 2026-11-09 | $244.1M | Gaingels, RA Capital Management, Dolby Family Ventures +2 | 11 to 50 | 2019 |
| INIA Biosciences | INIA Biosciences develops non-invasive, home-administered medical devices to manage chronic inflammatory diseases. | Biotech | Seed | $1.5M | 2026-09-08 | $1.5M | MassChallenge, MedTech Innovator | 1 to 10 | 2020 |
| Superluminal Medicines | Superluminal Medicines develops small-molecule therapeutics by combining AI, biology, and chemistry. | Artificial intelligence | Series B | $65.5M | 2026-09-03 | $223.5M | Insight Partners, RA Capital Management, NVentures | 11 to 50 | 2022 |
| Dash Bio | Dash Bio develops automated laboratory workflows and software to support drug development through bioanalysis services. | Artificial intelligence | Series A | $30.0M | 2026-08-03 | $47.5M | Freestyle Capital, Swift Ventures, LifeX Ventures +1 | 11 to 50 | 2024 |
| Ratio Therapeutics | Ratio Therapeutics develops radiopharmaceuticals to treat solid tumors in clinical trials. | Biotech | Series C | $70.0M | 2026-07-31 | $160.0M | Bristol-Myers Squibb, The Pags Group, Schusterman Family Investments | 11 to 50 | 2021 |
| InStockRx | InStockRx connects licensed pharmacies to buy and sell inventory with each other. | Commerce | Series A | $5.0M | 2026-07-01 | $5.1M | Techstars | 1 to 10 | 2020 |
| Cartwheel | Cartwheel makes first aid products for families, starting with head lice treatments. | Health care | Seed | $557K | 2026-06-25 | $557K | Health Wildcatters | 1 to 10 | 2023 |
| InStride Health | InStride Health provides evidence-based OCD and anxiety treatment to children and teenagers. | Health care | Series C | $30.0M | 2026-06-15 | $86.0M | General Catalyst, .406 Ventures, Mass General Brigham Ventures +2 | 251 to 500 | 2021 |
| Cerevance | Cerevance develops novel therapeutics for neurological diseases. | Biotech | Series C | $20.0M | 2026-05-12 | $209.5M | Google Ventures, Casdin Capital, Foresite Capital +1 | 51 to 100 | 2016 |
| AcuityMD | AcuityMD provides AI-powered data analysis to help companies make informed commercial decisions in healthcare. | Artificial intelligence | Series C | $80.0M | 2026-04-21 | $163.0M | Redpoint, Benchmark, ICONIQ Growth +2 | 251 to 500 | 2019 |
| Beacon Biosignals | Beacon Biosignals uses neurotechnology to measure brain activity for clinical trials and patient treatment. | Artificial intelligence | Series B | $11.0M | 2026-04-06 | $127.0M | General Catalyst, Half Court Ventures, Indicator Ventures +1 | 101 to 250 | 2019 |
| WHOOP Unicorn | WHOOP sells wearable fitness devices and a subscription service that tracks physiological data for performance insights. | Hardware | Series G | $575.0M | 2026-03-31 | $979.8M | Founder Collective, SoftBank Vision Fund, Foundry Group +2 | 501 to 1,000 | 2012 |
| Flourish Care | Flourish Care provides childbirth education, birth planning, and newborn care services. | Commerce | Seed | $5.7M | 2026-03-18 | $5.7M | MassChallenge, Texas HALO Fund | 11 to 50 | 2020 |
| Coral Care | Coral Care connects families with licensed speech, occupational, and physical therapists through a pediatric therapy platform. | Health care | Series A | $13.0M | 2026-02-23 | $19.5M | Hustle Fund, Reach Capital, AlleyCorp +2 | 11 to 50 | 2023 |
| Third Arc Bio | Third Arc Bio develops multifunctional antibodies for inflammatory and immunology diseases. | Biotech | Series A | $52.0M | 2026-02-04 | $217.0M | T. Rowe Price, Cormorant Asset Management, Foresite Capital +1 | 11 to 50 | 2022 |
| Precede Biosciences | Precede Biosciences develops blood-based tests that reveal disease-defining transcriptional biology. | Biotech | Series B | $63.5M | 2026-01-12 | $140.5M | Bristol-Myers Squibb, Lilly Asia Ventures, 5AM Ventures +2 | 11 to 50 | 2005 |
| Benchify | Benchify is a software development firm that offers a code review tool to help find bugs through testing. | Fintech | Seed | $500K | 2026-01-01 | $500K | Y Combinator, SAV (Scale Asia Ventures) | 1 to 10 | 2024 |
| Biometry | Biometry develops diagnostic tools for patients with chronic respiratory conditions. | Artificial intelligence | Seed | $2.2M | 2025-12-19 | $7.8M | MassChallenge, Elevate Ventures, Sidecar Angels +1 | 11 to 50 | 2013 |
| QSimulate | QSimulate applies quantum mechanics to solve large-scale industrial problems. | Health care | Seed | $2.5M | 2025-11-20 | $9.3M | National Science Foundation, IT-Farm, UTokyo Innovation Platform +2 | 11 to 50 | 2018 |
| AI Proteins | AI Proteins designs and engineers miniprotein therapeutics using artificial intelligence. | Artificial intelligence | Series A | $42.5M | 2025-11-19 | $80.4M | Intel Ignite, Lightchain Capital, Cobro Ventures | 11 to 50 | 2021 |
| FamilyWell Health | FamilyWell Health provides integrated mental health services for pregnant and postpartum patients. | Health care | Series A | $8.0M | 2025-11-18 | $13.3M | .406 Ventures, GreyMatter, Springboard Enterprises +1 | 11 to 50 | 2022 |
| VitVio | VitVio automates the administrative burden of hospital operating rooms so staff can focus on patients. | Artificial intelligence | Seed | $8.0M | 2025-10-23 | $10.0M | Microsoft for Startups, Nvidia Inception, LDV Capital +1 | 11 to 50 | 2023 |
| Elucid | Elucid applies AI to medical images to support precision medicine for cardiovascular disease. | Biotech | Series D | $36.5M | 2025-10-22 | $166.2M | National Science Foundation, Sand Hill Angels, IAG Capital Partners +1 | 101 to 250 | 2013 |
| Folia Health | Folia Health is a platform that securely captures and shares users' health and symptom data. | Biotech | Series A | $10.5M | 2025-10-01 | $17.4M | MassChallenge, Social Starts, Bantam Group +2 | 11 to 50 | 2016 |
| Eyebot | Eyebot develops eye examination technology to expand access to quality vision care. | Artificial intelligence | Series A | $20.0M | 2025-08-26 | $29.9M | National Science Foundation, Village Global, MassVentures +2 | 11 to 50 | 2021 |
| PhaseV | PhaseV provides AI-driven solutions for clinical development and operations. | Artificial intelligence | Series A | $50.0M | 2025-05-13 | $65.0M | Viola Ventures, LionBird, GETTY +1 | 11 to 50 | 2023 |
| Keragon | Keragon provides a HIPAA-compliant workflow automation platform. | Health care | Seed | $7.5M | 2025-02-12 | $10.5M | Afore Capital, focal, 25madison | 11 to 50 | 2022 |
| Lynx | Lynx provides an API-driven platform that lets businesses integrate healthcare financial services, payments, banking, and investments. | Fintech | Series A | $27.0M | 2025-02-06 | $44.5M | .406 Ventures, Obvious Ventures, Frist Cressey Ventures +2 | 11 to 50 | 2021 |
| VideaHealth | VideaHealth offers dentistAI software that automatically detects pathologies in dental imaging to help dentists avoid missed diagnoses. | Biotech | Series B | $40.0M | 2025-01-28 | $66.5M | Spark Capital, Zetta Venture Partners, Pillar VC +2 | 51 to 100 | 2018 |
| ZETA SURGICAL | ZETA SURGICAL provides real-time frameless navigation for brain surgery, deployable beyond the operating room. | Artificial intelligence | Series A | $5.0M | 2025-01-21 | $13.9M | Y Combinator, Artesian VC, Brinc +2 | 11 to 50 | 2018 |
Table 1. Health care startups in Boston, Massachusetts: the 30 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 438.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | WHOOP Unicorn | WHOOP sells wearable fitness devices and a subscription service that tracks physiological data for performance insights. | Hardware | Series G | $575.0M | 2026-03-31 | $979.8M | Founder Collective, SoftBank Vision Fund, Foundry Group +2 | 501 to 1,000 | 2012 |
| 2 | Delix Therapeutics | Delix Therapeutics develops psychoplastogen therapies that promote neuroplasticity. | Biotech | Series C | $100.0M | 2026-11-09 | $244.1M | Gaingels, RA Capital Management, Dolby Family Ventures +2 | 11 to 50 | 2019 |
| 3 | AcuityMD | AcuityMD provides AI-powered data analysis to help companies make informed commercial decisions in healthcare. | Artificial intelligence | Series C | $80.0M | 2026-04-21 | $163.0M | Redpoint, Benchmark, ICONIQ Growth +2 | 251 to 500 | 2019 |
| 4 | Ratio Therapeutics | Ratio Therapeutics develops radiopharmaceuticals to treat solid tumors in clinical trials. | Biotech | Series C | $70.0M | 2026-07-31 | $160.0M | Bristol-Myers Squibb, The Pags Group, Schusterman Family Investments | 11 to 50 | 2021 |
| 5 | Superluminal Medicines | Superluminal Medicines develops small-molecule therapeutics by combining AI, biology, and chemistry. | Artificial intelligence | Series B | $65.5M | 2026-09-03 | $223.5M | Insight Partners, RA Capital Management, NVentures | 11 to 50 | 2022 |
| 6 | Precede Biosciences | Precede Biosciences develops blood-based tests that reveal disease-defining transcriptional biology. | Biotech | Series B | $63.5M | 2026-01-12 | $140.5M | Bristol-Myers Squibb, Lilly Asia Ventures, 5AM Ventures +2 | 11 to 50 | 2005 |
| 7 | Third Arc Bio | Third Arc Bio develops multifunctional antibodies for inflammatory and immunology diseases. | Biotech | Series A | $52.0M | 2026-02-04 | $217.0M | T. Rowe Price, Cormorant Asset Management, Foresite Capital +1 | 11 to 50 | 2022 |
| 8 | AI Proteins | AI Proteins designs and engineers miniprotein therapeutics using artificial intelligence. | Artificial intelligence | Series A | $42.5M | 2025-11-19 | $80.4M | Intel Ignite, Lightchain Capital, Cobro Ventures | 11 to 50 | 2021 |
| 9 | Dash Bio | Dash Bio develops automated laboratory workflows and software to support drug development through bioanalysis services. | Artificial intelligence | Series A | $30.0M | 2026-08-03 | $47.5M | Freestyle Capital, Swift Ventures, LifeX Ventures +1 | 11 to 50 | 2024 |
| 10 | InStride Health | InStride Health provides evidence-based OCD and anxiety treatment to children and teenagers. | Health care | Series C | $30.0M | 2026-06-15 | $86.0M | General Catalyst, .406 Ventures, Mass General Brigham Ventures +2 | 251 to 500 | 2021 |
Table 2. Health care startups in Boston, Massachusetts: the 10 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | MassChallenge | Startup accelerator | Boston, United States | 18 | 4% | 3 | INIA Biosciences, Flourish Care, Biometry |
| 2 | Techstars | Startup accelerator | New York, United States | 11 | 3% | 1 | InStockRx |
| 3 | Alumni Ventures | Angel group | Manchester, United States | 8 | 2% | ||
| 4 | Y Combinator | Startup accelerator | Mountain View, United States | 8 | 2% | 1 | Benchify |
| 5 | .406 Ventures | Venture capital firm | Boston, United States | 7 | 2% | 2 | InStride Health, FamilyWell Health |
| 6 | National Science Foundation | Entrepreneurship program | Alexandria, United States | 6 | 1% | 1 | QSimulate |
| 7 | General Catalyst | Venture capital firm | San Francisco, United States | 4 | 1% | 2 | InStride Health, Beacon Biosignals |
| 8 | Pillar VC | Venture capital firm | Boston, United States | 4 | 1% | ||
| 9 | Insight Partners | Private equity firm | New York, United States | 3 | 1% | 1 | Superluminal Medicines |
| 10 | Fidelity | Investment bank | Boston, United States | 3 | 1% | ||
| 11 | Flare Capital Partners | Venture capital firm | Boston, United States | 3 | 1% | ||
| 12 | LaunchPad Venture | Angel group | Newton, United States | 3 | 1% | ||
| 13 | Social Starts | Micro VC fund | San Francisco, United States | 3 | 1% | ||
| 14 | Google Ventures | Corporate venture arm | San Francisco, United States | 3 | 1% | 1 | Cerevance |
| 15 | OrbiMed | Private equity firm | New York, United States | 3 | 1% |
Table 3. Health care startups in Boston, Massachusetts: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Biotech | 175 | 40% | $10.4B |
| Software | 147 | 34% | $4.5B |
| Artificial intelligence | 78 | 18% | $2.7B |
| Hardware | 25 | 6% | $1.4B |
| Commerce | 19 | 4% | $173.4M |
| Fintech | 14 | 3% | $231.0M |
| Education | 12 | 3% | $69.8M |
| Energy | 1 | 0% | $2.1M |
| Cybersecurity | 1 | 0% | $5.5M |
Table 4. Health care startups in Boston, Massachusetts by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
Table 5. Health care startups in Boston, Massachusetts by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| November 2026 | 3 | 4% | $116.9M |
| October 2026 | 4 | 6% | $190.3M |
| September 2026 | 9 | 13% | $336.4M |
| August 2026 | 6 | 8% | $106.4M |
| July 2026 | 3 | 4% | $75.1M |
| June 2026 | 7 | 10% | $95.1M |
| May 2026 | 2 | 3% | $20.0M |
| April 2026 | 5 | 7% | $110.3M |
| March 2026 | 4 | 6% | $599.7M |
| February 2026 | 6 | 8% | $71.8M |
| January 2026 | 12 | 17% | $409.0M |
| December 2025 | 4 | 6% | $11.7M |
| November 2025 | 6 | 8% | $210.2M |
Table 6. Health care startups in Boston, Massachusetts: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 61 | 14% | $2.1B |
| 2025 | 73 | 17% | $1.4B |
| 2024 | 40 | 9% | $1.6B |
| 2023 | 39 | 9% | $800.3M |
| 2022 | 51 | 12% | $821.4M |
| 2021 | 41 | 9% | $984.2M |
Table 7. Health care startups in Boston, Massachusetts by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 79 | 18% |
| 2020 to 2022 | 94 | 22% |
| 2015 to 2019 | 165 | 38% |
| 2010 to 2014 | 67 | 16% |
| Before 2010 | 27 | 6% |
Table 8. Health care startups in Boston, Massachusetts by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 174 | 41% |
| 11 to 50 | 179 | 42% |
| 51 to 100 | 32 | 7% |
| 101 to 250 | 26 | 6% |
| 251 to 500 | 10 | 2% |
| 501 to 1,000 | 5 | 1% |
| 1,001 to 5,000 | 1 | 0% |
Table 9. Health care startups in Boston, Massachusetts by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Health care is one of its sectors and its headquarters is in Boston, Massachusetts. On 16 November 2026 that is 438 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 30 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 438 rows: 93 have no round amount, 0 no city and 52 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many health care startups in Boston, Massachusetts are on the list?
- 438, in the file dated 16 November 2026. 71 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 438 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.